Aeolus Pharmaceuticals, Inc. (AOLS)

Aeolus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Cash & Equivalents	0.4	3.16	0.09	1.52	0.87	0.28
Cash & Short-Term Investments	0.4	3.16	0.09	1.52	0.87	0.28
Cash Growth	-89.27%	3256.38%	-93.80%	74.57%	209.25%	-45.75%
Receivables	0.31	0.75	1.59	1.56	0.37	0.78
Prepaid Expenses	0.05	0.23	0.05	0.05	0.04	0.06
Other Current Assets	-	-	0.02	0.43	0.66	0.1
Total Current Assets	0.76	4.14	1.75	3.55	1.93	1.22
Long-Term Investments	0.03	0.03	0.03	0.03	0.03	0.03
Total Assets	0.79	4.17	1.78	3.58	1.97	1.26
Accounts Payable	0.59	0.97	1.6	1.55	0.58	2.17
Short-Term Debt	-	-	1	-	-	-
Current Unearned Revenue	-	-	0.02	0.44	0.68	0.11
Total Current Liabilities	0.59	0.97	2.62	2	1.26	2.27
Other Long-Term Liabilities	-	-	-	-	-	19.32
Total Liabilities	0.59	0.97	2.62	2	1.26	21.59
Common Stock	1.52	1.52	1.36	1.36	1.35	0.63
Additional Paid-In Capital	191.95	191.86	184.42	184.22	183.28	159.75
Retained Earnings	-193.26	-190.19	-186.63	-184	-183.92	-180.71
Total Common Equity	0.21	3.2	-0.85	1.58	0.7	-20.34
Shareholders' Equity	0.21	3.2	-0.85	1.59	0.71	-20.34
Total Liabilities & Equity	0.79	4.17	1.78	3.58	1.97	1.26
Total Debt	-	-	1	-	-	-
Net Cash (Debt)	0.4	3.16	-0.91	1.52	0.87	0.28
Net Cash Growth	-89.27%	-	-	74.57%	209.25%	-45.75%
Net Cash Per Share	0.00	0.02	-0.01	0.01	0.01	0.00
Filing Date Shares Outstanding	152.09	152.09	135.93	135.85	134.55	62.73
Total Common Shares Outstanding	152.09	152.09	135.93	135.85	134.55	62.73
Working Capital	0.18	3.16	-0.88	1.55	0.67	-1.05
Book Value Per Share	0.00	0.02	-0.01	0.01	0.01	-0.32
Tangible Book Value	0.21	3.2	-0.85	1.58	0.7	-20.34
Tangible Book Value Per Share	0.00	0.02	-0.01	0.01	0.01	-0.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.